PL380481A1 - Kompozycje do leczenia infekcji u bydła i świń - Google Patents
Kompozycje do leczenia infekcji u bydła i świńInfo
- Publication number
- PL380481A1 PL380481A1 PL380481A PL38048104A PL380481A1 PL 380481 A1 PL380481 A1 PL 380481A1 PL 380481 A PL380481 A PL 380481A PL 38048104 A PL38048104 A PL 38048104A PL 380481 A1 PL380481 A1 PL 380481A1
- Authority
- PL
- Poland
- Prior art keywords
- swine
- cattle
- compositions
- treating infection
- infection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Gynecology & Obstetrics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Pregnancy & Childbirth (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47429403P | 2003-05-29 | 2003-05-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL380481A1 true PL380481A1 (pl) | 2007-02-05 |
Family
ID=33551488
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04753639T PL1626739T3 (pl) | 2003-05-29 | 2004-05-28 | Kompozycje zawierające florfenikol lub strukturalnie pokrewny związek do leczenia infekcji u bydła i trzody chlewnej |
PL380481A PL380481A1 (pl) | 2003-05-29 | 2004-05-28 | Kompozycje do leczenia infekcji u bydła i świń |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04753639T PL1626739T3 (pl) | 2003-05-29 | 2004-05-28 | Kompozycje zawierające florfenikol lub strukturalnie pokrewny związek do leczenia infekcji u bydła i trzody chlewnej |
Country Status (24)
Country | Link |
---|---|
US (2) | US8034845B2 (pl) |
EP (1) | EP1626739B1 (pl) |
JP (2) | JP4728244B2 (pl) |
KR (1) | KR101132079B1 (pl) |
CN (2) | CN102342925A (pl) |
AR (2) | AR044437A1 (pl) |
AU (2) | AU2004247053B2 (pl) |
BR (1) | BRPI0410795B1 (pl) |
CA (1) | CA2526202C (pl) |
CL (1) | CL2004001293A1 (pl) |
EC (1) | ECSP056189A (pl) |
ES (1) | ES2492537T3 (pl) |
IL (1) | IL172224A0 (pl) |
MX (1) | MXPA05012827A (pl) |
MY (1) | MY146351A (pl) |
NO (1) | NO20056223L (pl) |
NZ (1) | NZ543594A (pl) |
PE (1) | PE20050386A1 (pl) |
PL (2) | PL1626739T3 (pl) |
RU (1) | RU2359659C2 (pl) |
TW (1) | TW200505425A (pl) |
UA (1) | UA81676C2 (pl) |
WO (1) | WO2004110494A1 (pl) |
ZA (1) | ZA200509544B (pl) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11337894B2 (en) | 2018-06-15 | 2022-05-24 | James T. Doubet | Syringe adapter for animal medication |
US10709850B2 (en) | 2018-06-15 | 2020-07-14 | James T. Doubet | Syringe adapter for medication |
US11090444B2 (en) | 2018-06-15 | 2021-08-17 | James T. Doubet | Syringe adapter for medication |
US11097058B2 (en) | 2018-06-15 | 2021-08-24 | James T. Doubet | Syringe adapter for medication |
US20020035107A1 (en) * | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US6790867B2 (en) * | 2002-05-20 | 2004-09-14 | Schering-Plough Animal Health Corporation | Compositions and method for treating infection in cattle and swine |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
UA82359C2 (uk) * | 2003-04-03 | 2008-04-10 | Schering Plough Ltd | Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин |
MY146351A (en) | 2003-05-29 | 2012-08-15 | Schering Plough Ltd | Compositions for treating infection in cattle and swine |
EP1568369A1 (en) * | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
MX2007007528A (es) * | 2004-12-21 | 2007-10-08 | Intervet Int Bv | Composicion veterinaria inyectable. |
GB0501220D0 (en) * | 2005-01-21 | 2005-03-02 | Norbrook Lab Ltd | Anthelmintic composition |
KR101438177B1 (ko) * | 2006-11-01 | 2014-09-05 | 프로노바 바이오파마 너지 에이에스 | 페록시솜 증식자-활성화 수용체의 활성자 또는 조절자인 알파-치환된 오메가-3 지질 |
EP2129646A2 (en) * | 2006-11-01 | 2009-12-09 | Pronova Biopharma Norge AS | Omega-3 lipid compounds |
CA2672795A1 (en) * | 2006-12-13 | 2008-06-26 | Schering-Plough Ltd. | Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof |
RU2009127496A (ru) * | 2006-12-19 | 2011-01-27 | Шеринг-Плоу Лтд. (CH) | Шипучие препараты флорфеникола для добавления в системы питьевой воды |
PE20091171A1 (es) * | 2007-12-14 | 2009-08-03 | Schering Plough Ltd | Proceso para recuperar florfenicol y analogos de florfenicol |
FR2925334A1 (fr) * | 2007-12-21 | 2009-06-26 | Ceva Sante Animale Sa | Nouvelles compositions antibacteriennes |
CN102131772B (zh) * | 2008-07-30 | 2015-03-11 | 英特威国际有限公司 | 用作氟苯尼考的中间体的*唑啉-保护的氨基二醇化合物的制备方法 |
IN2012DN03157A (pl) | 2009-10-12 | 2015-09-18 | Boehringer Ingelheim Vetmed | |
KR101140167B1 (ko) * | 2009-11-04 | 2012-04-24 | 최기동 | 동물용 의약 조성물 및 이를 포함하는 동물용 의약품 |
BRPI1002021A2 (pt) | 2010-01-21 | 2012-05-22 | Nanocore Biotecnologia S A | composições farmacêuticas para tratamento de infecções bacterianas |
BRPI1002023A2 (pt) | 2010-03-01 | 2011-10-25 | Nanocore Biotecnologia S A | forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas |
US9149480B2 (en) | 2010-03-03 | 2015-10-06 | Boehringer Ingeleheim Vetmedica GmbH | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
DK2654785T3 (da) * | 2010-12-22 | 2019-06-24 | Bayer Ip Gmbh | Forøget immunrespons hos kvægracer |
EA028412B9 (ru) * | 2014-08-08 | 2018-03-30 | Александр Петрович Мерабишвили | Фармацевтический препарат ветеринарного назначения |
EA028381B1 (ru) * | 2014-08-08 | 2017-11-30 | Александр Петрович Мерабишвили | Фармацевтический препарат ветеринарного назначения |
RU2563826C1 (ru) * | 2014-08-21 | 2015-09-20 | Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" | Инъекционная антибактериальная фармацевтическая композиция |
AU2016282879A1 (en) * | 2015-06-26 | 2018-01-18 | Bayer Animal Health Gmbh | Methods of modulating cytosolic DNA surveillance molecules |
US20180187263A1 (en) * | 2017-01-05 | 2018-07-05 | Iowa State University Research Foundation, Inc. | Kits for diagnostic detection and prevention of feedlot bovine respiratory disease |
USD890925S1 (en) | 2018-06-15 | 2020-07-21 | James T. Doubet | Syringe adapter for medication |
US20190388625A1 (en) | 2018-06-15 | 2019-12-26 | James T. Doubet | Syringe adapter for medication |
US20210292284A1 (en) * | 2018-06-25 | 2021-09-23 | Intervet Inc. | Compounds useful for the treatment of infection with mannheimia haemolytica or histophilus somni |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2671748A (en) * | 1950-05-18 | 1954-03-09 | Parke Davis & Co | Composition of matter |
ES488154A0 (es) | 1979-02-05 | 1981-04-16 | Schering Corp | Un procedimiento para la preparacion de un compuesto d-(treo-1-aril-2-acilamido-3-fluor-1-propanol |
US4235892A (en) * | 1979-02-05 | 1980-11-25 | Schering Corporation, Patent Dept. | 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor |
US5105009A (en) | 1983-06-02 | 1992-04-14 | Zambon S.P.A. | Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives |
NZ234802A (en) * | 1989-08-14 | 1992-11-25 | Merck & Co Inc | Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals |
US5082863A (en) * | 1990-08-29 | 1992-01-21 | Schering Corporation | Pharmaceutical composition of florfenicol |
US5663361A (en) | 1996-08-19 | 1997-09-02 | Schering Corporation | Process for preparing intermediates to florfenicol |
US6130200A (en) * | 1996-12-20 | 2000-10-10 | Alza Corporation | Gel composition and methods |
TR199902748T2 (xx) | 1997-05-06 | 2000-05-22 | Norbrook Laboratories Limited | Uzun s�re etkili antimikrobik maddelerle ilgili geli�meler |
CA2211949A1 (en) * | 1997-07-21 | 1999-01-29 | David Farley Johnson | Nonaqueous compositions for parenteral administration |
JP2003512290A (ja) | 1997-09-10 | 2003-04-02 | メルク エンド カムパニー インコーポレーテッド | 家畜抗菌剤としての8a−アザライド |
KR100499438B1 (ko) * | 1997-12-03 | 2005-07-07 | 머크 앤드 캄파니 인코포레이티드 | 수소화 피마자유를 함유하는 지속성 주사제 |
ES2359973T3 (es) * | 1998-03-19 | 2011-05-30 | MERCK SHARP & DOHME CORP. | Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas. |
US6136838A (en) * | 1998-03-19 | 2000-10-24 | Merck & Co., Inc. | Sulfurpentafluorophenylpyrazoles for controlling ectoparasitic infestations |
US6174540B1 (en) * | 1998-09-14 | 2001-01-16 | Merck & Co., Inc. | Long acting injectable formulations containing hydrogenated caster oil |
JP2001226257A (ja) * | 2000-02-17 | 2001-08-21 | Material Eng Tech Lab Inc | 溶液製剤 |
US6787568B1 (en) | 2000-11-27 | 2004-09-07 | Phoenix Scientific, Inc. | Antibiotic/analgesic formulation and a method of making this formulation |
DE60129156T2 (de) * | 2000-11-29 | 2008-03-13 | Lyotropic Therapeutics, Inc. | Lösungsmittelsysteme für pharmazeutische mittel |
TW200406372A (en) | 2002-03-08 | 2004-05-01 | Schering Plough Ltd | Novel florfenicol-type antibiotics |
US6790867B2 (en) * | 2002-05-20 | 2004-09-14 | Schering-Plough Animal Health Corporation | Compositions and method for treating infection in cattle and swine |
CN1507858A (zh) | 2002-12-19 | 2004-06-30 | 王玉万 | 含氟化氯霉素的兽用液体制剂 |
UA82359C2 (uk) * | 2003-04-03 | 2008-04-10 | Schering Plough Ltd | Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин |
WO2005000869A1 (en) * | 2003-05-29 | 2005-01-06 | Washington University | Neuroactive 13,24-cyclo-18,21-dinorcholanes and structurally-related pentacyclic steroids |
MY146351A (en) | 2003-05-29 | 2012-08-15 | Schering Plough Ltd | Compositions for treating infection in cattle and swine |
JP4719160B2 (ja) | 2003-12-23 | 2011-07-06 | シェーリング−プラウ・リミテッド | 改善された水溶性を有するフロルフェニコールプロドラッグ |
US7361689B2 (en) | 2003-12-31 | 2008-04-22 | Schering-Plough Animal Health Corporation | Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof |
MX2007007528A (es) | 2004-12-21 | 2007-10-08 | Intervet Int Bv | Composicion veterinaria inyectable. |
JP2009507842A (ja) | 2005-09-07 | 2009-02-26 | シェーリング−プラウ・リミテッド | フロルフェニコールに対する中間体として有用なオキサゾリジンで保護されたアミノジオール化合物を調製するためのプロセス |
US8119667B2 (en) | 2005-12-29 | 2012-02-21 | Schering-Plough Animal Health Corporation | Carbonates of fenicol antibiotics |
EP2091909A1 (en) | 2006-12-13 | 2009-08-26 | Schering-Plough Ltd. | Water-soluble prodrugs of florfenicol and its analogs |
US20080153906A1 (en) | 2006-12-13 | 2008-06-26 | Celly Chander S | Water-Soluble Phenicol Prodrugs in a Lipophilic Vehicle System |
CA2672795A1 (en) | 2006-12-13 | 2008-06-26 | Schering-Plough Ltd. | Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof |
RU2009127496A (ru) | 2006-12-19 | 2011-01-27 | Шеринг-Плоу Лтд. (CH) | Шипучие препараты флорфеникола для добавления в системы питьевой воды |
EP2150245A1 (en) | 2007-04-27 | 2010-02-10 | Schering-Plough Ltd. | Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins |
MX2009013016A (es) | 2007-05-30 | 2010-02-17 | Schering Plough Ltd | Un procedimiento para preparar compuestos de aminodiol oxazolina-protegidos utiles como intermediarios para florfenicol. |
EP2173726A2 (en) | 2007-07-25 | 2010-04-14 | Intervet International B.V. | Process for preparing oxazolidine- and oxazolidinone-aminodiols |
RU2010123282A (ru) | 2007-11-09 | 2011-12-20 | Интэрвэт Интэрнэшнл Б.Ф. (NL) | Твердая лекарственная форма с быстрым высвобождением активного вещества, ее получение и применение |
PE20091171A1 (es) | 2007-12-14 | 2009-08-03 | Schering Plough Ltd | Proceso para recuperar florfenicol y analogos de florfenicol |
-
2004
- 2004-05-27 MY MYPI20042043A patent/MY146351A/en unknown
- 2004-05-27 TW TW093115129A patent/TW200505425A/zh unknown
- 2004-05-27 AR ARP040101824A patent/AR044437A1/es not_active Application Discontinuation
- 2004-05-27 PE PE2004000537A patent/PE20050386A1/es active IP Right Grant
- 2004-05-27 CL CL200401293A patent/CL2004001293A1/es unknown
- 2004-05-28 CN CN2011102107601A patent/CN102342925A/zh active Pending
- 2004-05-28 NZ NZ543594A patent/NZ543594A/en not_active IP Right Cessation
- 2004-05-28 PL PL04753639T patent/PL1626739T3/pl unknown
- 2004-05-28 CN CNA2004800145293A patent/CN1795013A/zh active Pending
- 2004-05-28 PL PL380481A patent/PL380481A1/pl not_active Application Discontinuation
- 2004-05-28 AU AU2004247053A patent/AU2004247053B2/en not_active Expired
- 2004-05-28 MX MXPA05012827A patent/MXPA05012827A/es active IP Right Grant
- 2004-05-28 ES ES04753639.6T patent/ES2492537T3/es not_active Expired - Lifetime
- 2004-05-28 WO PCT/US2004/016841 patent/WO2004110494A1/en active Application Filing
- 2004-05-28 BR BRPI0410795-0A patent/BRPI0410795B1/pt active IP Right Grant
- 2004-05-28 UA UAA200512427A patent/UA81676C2/ru unknown
- 2004-05-28 US US10/857,695 patent/US8034845B2/en active Active
- 2004-05-28 RU RU2005141127/15A patent/RU2359659C2/ru active
- 2004-05-28 CA CA2526202A patent/CA2526202C/en not_active Expired - Lifetime
- 2004-05-28 KR KR1020057022452A patent/KR101132079B1/ko not_active IP Right Cessation
- 2004-05-28 JP JP2006533475A patent/JP4728244B2/ja not_active Expired - Lifetime
- 2004-05-28 EP EP04753639.6A patent/EP1626739B1/en not_active Expired - Lifetime
-
2005
- 2005-11-24 ZA ZA200509544A patent/ZA200509544B/en unknown
- 2005-11-28 IL IL172224A patent/IL172224A0/en unknown
- 2005-11-28 EC EC2005006189A patent/ECSP056189A/es unknown
- 2005-12-29 NO NO20056223A patent/NO20056223L/no not_active Application Discontinuation
-
2007
- 2007-05-24 JP JP2007138359A patent/JP2007269801A/ja active Pending
-
2010
- 2010-10-18 AU AU2010235885A patent/AU2010235885A1/en not_active Abandoned
-
2011
- 2011-09-02 US US13/224,739 patent/US9084719B2/en active Active
-
2015
- 2015-07-30 AR ARP150102442A patent/AR101380A2/es not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL172224A0 (en) | Compositions for treating infection in cattle and swine | |
HK1072547A1 (en) | Compositions and method for treating infection in cattle and swine | |
ZA200507857B (en) | Compositions for treating microbial and parasitic infections in cattle and other animals | |
AU2003284242A8 (en) | Methods and compositions for use in treating cancer | |
IL172194A0 (en) | Methods and compositions for treating amyloid-related diseases | |
HK1089676A1 (en) | Formulations and methods for treating rhinosinusitis | |
HK1150751A1 (en) | Methods for preventing and treating tissue damage associated with ischemia- reperfusion injury | |
HK1074005A1 (en) | Compositions and methods for treating or preventing pneumococcal infection | |
IL173868A0 (en) | Rage-related methods and compositions for treating glomerular injury | |
EP1461047A4 (en) | COMPOSITIONS AND METHODS FOR TREATING ANIMALS | |
SG118236A1 (en) | Compositions and methods for treating coronavirus infection and SARS | |
EP1663283A4 (en) | GLUTAMINE FOR THE TREATMENT OF LESION | |
AU2002358036A1 (en) | Methods and compositions for use in pet breeding | |
AU2003239132A8 (en) | Methods and compositions for preventing and treating microbial infections | |
AU2003259202A8 (en) | Compositions and methods for treating and preventing infection | |
SG110107A1 (en) | Compound and use in treatment | |
IL166062A0 (en) | Compositions and methods for therapeutic treatment | |
EP1608232A4 (en) | METHOD AND COMPOSITIONS FOR IMPROVING ANIMAL HEALTH | |
AU2003275433A8 (en) | Compositions and methods for treating pain | |
AU2003269378A8 (en) | Methods and compositions for diagnosing and treating companion animal cancer | |
AU2003298708A8 (en) | Gpc99 and gpc99a: methods and compositions for treating cancer | |
EP1599214A4 (en) | METHODS AND COMPOSITIONS FOR TREATING UTERINE COLON CANCER | |
IL166122A0 (en) | Methods of treating microbial infections in humansand animals | |
IL163878A0 (en) | Compositions and methods for treating mdma-inducedtoxicity | |
AU2003295604A8 (en) | Gpc15: methods and compositions for treating cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |